Bayer CropScience LP provides crop protection products. The company was founded on December 3, 1999 and is headquartered in Research Triangle Park, NC.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Genecor, Inc. provides engineering services. The company is headquartered in Quebec City, Canada.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

Probelte SA is a company headquartered in Espinardo, Spain. The firm wholesales and distributes plant protection products. It was founded in 1970. Arturo Lizon is the CEO, in this role since 2020.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

As a leader in innovative biological and low-chemical pest management solutions, AgraQuest is at the forefront of a shift in how food is grown. AgraQuest focuses on discovering, developing, manufacturing and marketing highly effective biological and low-chemical pest, disease control and yield enhancing products for the agricultural, home & garden and food safety markets. Through its Agrochemical and BioInnovations Divisions, AgraQuest provides its customers and partners with tools to create value-enhancing solutions. AgraQuest has its own direct sales force in the NAFTA crop protection markets, and sells its products through a network of distributors and partners in other global regions as well as in several non agriculture related markets. Through its Agrochemical Division, AgraQuest is redefining the agrochemical industry with the introduction of effective, innovative and environmentally responsible pest and disease control products and services. AgraQuest is the premier supplier of proprietary, data-driven biological and low-chemical technology, and unlike many conventional pesticides which are made using petroleum-based or other synthetic chemicals, AgraQuest’s products are produced from renewable, bio-based materials. As part of the clean-tech revolution, AgraQuest’s BioInnovations Division is developing cutting edge technologies for use in seed treatment, food safety, post-harvest disease control, animal health and hygiene, human nutrition, home and garden, structural pest control, and vector control. Additional applications for AgraQuest’s technologies lie in areas as diverse as detergents, cosmetics and healthcare.

Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

DSM Austria GmbH operates as a holding company that engages in the fields of food and feed safety. Its business activities focus on the development of natural feed additives, feed and food analysis, and plant protection. The company was founded in 1995 and is headquartered in Getzersdorf, Austria.

FMC Corporation is an U.S.-based chemical manufacturing company producing chemical solutions for the agricultural, textile, and healthcare industries. The company was founded in California in 1883 when John Bean invented the first piston sprayer for agriculture. FMC Corporation owns superior technology and strong partnerships with customers, and continues to invest in finding solutions that are helping to change people's lives for the better. Today, FMC maintains leading positions in three chemical markets: Agricultural, Specialty, and Industrial. The company uses an array of advanced technologies in research and development, mining and manufacturing to produce customized products and solutions for the many markets they serve. As a global leader utilizing advanced technologies and customer-focused research and development, FMC provides innovative and cost-effective solutions to food and agriculture, pharmaceutical, healthcare, pulp and paper, textiles, glass and ceramics, rubber and plastics, lubricants, structural pest control, turf & ornamental markets, specialty and related industries.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

BioGaia is an innovative Swedish health care company

Shin-Etsu Chemical Co., Ltd. engages in the manufacture and sale of industrial chemicals. Its operations are carried out through the following segments: Polyvinyl Chloride (PVC)/Chlor-Alkali Business, Silicone Business, Specialty Chemicals Business, Semiconductor Silicon Business, Electronics and Functional Materials Business, and Diversified Business. The PVC/Chlor-Alkali Business segment provides PVC, caustic soda, methanol, and chloromethane. The Silicone Business segment provides silicones. The Specialty Chemicals Business segment provides cellulose derivatives, silicon metal, polyvinyl alcohol, and synthetic pheromones. The Semiconductor Silicon Business segment provides silicon wafer products. The Electronics and Functional Materials Business segment provides rare earth magnets, coating materials, photomask blanks, oxide single crystals, and liquid fluoroelastomers. The Diversified Business segment includes processed plastics, international trading, engineering, ad information processing. The company was founded on September 16, 1926 and is headquartered in Tokyo, Japan.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocata’s intellectual property portfolio includes pluripotent stem cell platforms – hESC and induced pluripotent stem cell (iPSC) – and other cell therapy research programs.